Safety and Tolerability of E5555 and Its Effects on Markers of Intravascular Inflammation in Subjects With Coronary Artery Disease
Clinical trial NCT00312052 · COMPLETED
Trial details
- NCT number
- NCT00312052
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-09-01
- Primary completion
- 2008-03-01
- Enrollment
- 720
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.